| ²é¿´: 539 | »Ø¸´: 0 | |||
ÖпÆÐÂÉúÃüÌú³æ (³õÈëÎÄ̳)
|
[½»Á÷]
×éѧ´óÅ£Matthias MannÀûÓÃ4Dµ°°××éѧ½Òʾйڲ¡¶¾ÓÕµ¼µÄÐļ¡Ñ×·Ö×ÓÌØÕ÷
|
|
Ñ×Ö¢ÐÔÐ¡ÊÇÒ»ÖÖÒÔÐÄÔàÃâÒßϸ°û½þÈóÎªÌØÕ÷µÄ³£¼û¼²²¡£¬³£Óɲ¡¶¾¡¢ÏµÍ³ÐÔÃâÒßÎÉÂÒºÍÒ©Îï¶¾ÐÔÒýÆð¡£½üÆÚ·¢ÏÖSARS-CoV-2¸ÐȾµÄ»¼ÕßÒ²°éÓÐÑ×Ö¢ÐÔÐ¡£¬µ«ÊÇÆä¾ßÌåµÄ·Ö×ÓÌØÕ÷ÈÔδ֪¡£ 2021Äê12Ô£¬µÂ¹úÐÄѪ¹ÜÑо¿ÖÐÐÄChristian SchulzºÍÂí¿Ë˹¡¤ÆÕÀÊ¿ËÉúÎﻯѧÑо¿ËùMatthias MannµÈÍŶӺÏ×÷ÔÚÐÄѪ¹ÜҽѧÁìÓòȨÍþÆÚ¿¯JAMA Cardiology£¨IF 14.7£©ÔÓÖ¾ÉÏ·¢±íÁËһƪ²ÎÓëµÄÌâΪ¡°Association of Complement and MAPK Activation With SARS-CoV-2¨CAssociated Myocardial Inflammation¡±µÄÎÄÕ¡£¸ÃÎÄÕÂÀûÓÃ4Dµ°°××éѧ¼¼ÊõºÍת¼×éѧ¼¼ÊõÆÀ¹ÀÁËSARS-CoV-2¸ÐȾ»¼ÕßÒÔ¼°²¡¶¾ºÍÃâÒ߽鵼µÄÐļ¡Ñ×»¼ÕßÐÄÔàµÄ·Ö×ÓÌØÕ÷¡£ Ñо¿²ÄÁÏ ·ÇSARS-CoV-2²¡¶¾ÐÔÐļ¡Ñס¢ÃâÒ߽鵼Ðļ¡Ñס¢·ÇÑ×Ö¢ÐÔÐ¡¡¢SARS-CoV-2²¡¶¾ÐÔÐļ¡Ñ×»¼ÕßÐÄÔà×éÖ¯µÄ¸£¶ûÂíÁ̶ֹ¨Ê¯À¯°üÂñ (FFPE) Ñù±¾ ¼¼Êõ·Ïß ¡¤ ²½Öè1£º²»Í¬Ðļ¡Ñ×»¼ÕßµÄÃâÒßÌØÕ÷·ÖÎö£» ¡¤ ²½Öè2£º²»Í¬Ðļ¡Ñ×»¼Õߵĵ°°××éѧºÍת¼×éѧ·ÖÎö£» ¡¤ ²½Öè3£º¸»¼¯Í¨Â·µÄÉîÈë·ÖÎö¡£ С½á ÔÚ19Ãû²ÎÓëÕßÖУ¬Ðļ¡Ñ×»¼ÕßÐļ¡×éÖ¯ÖÐCD163+¾ÞÊÉϸ°ûµÄ·á¶ÈÆÕ±é½Ï¸ß£¬¶øÓë·ÇSARS-CoV-2²¡¶¾Ïà¹ØºÍÃâÒ߽鵼µÄÐļ¡Ñ×»¼ÕßÏà±È£¬SARS-CoV-2¸ÐȾ»¼ÕßÐļ¡×éÖ¯ÖеÄÁܰÍϸ°û¼ÆÊý½ÏµÍ¡£ÔÚSARS-CoV-2¸ÐȾ»¼ÕßÖУ¬²¹Ìå¼¶Áª·´Ó¦µÄ×é³É³É·Ö£¬°üÀ¨C1qÑÇ»ùºÍË¿°±Ëá/°ëë×°±Ëáµ°°×øÒÖÖÆ¼Á·ÖÖ§G³ÉÔ±1ÔÚµ°°××éºÍת¼×éÖоù½ÏÆäËû×黼ÕßÏÔÖøÉϵ÷¡£ÔÚÐÄÔà¾ÞÊÉϸ°ûÖУ¬C1q·á¶ÈÔÚSARS-CoV-2¸ÐȾÖÐ×î¸ß¡£¶ÔÖØÒªÐźż¶ÁªµÄÆÀ¹À·¢ÏÖË¿°±Ëá/ËÕ°±ËáË¿ÁÑÔ¼¤»îµÄµ°°×¼¤Ã¸Í¨Â·Ò²ÏÔÖøÉϵ÷¡£ µã»÷Á´½ÓÁ˽âÎÄÕÂÏêÇ飺https://mp.weixin.qq.com/s/L5UpM_YuFa5EsOg7QfV8Kw |
» ²ÂÄãϲ»¶
323Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ 070300 ѧ˶ 336·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
352Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¶«»ª´óѧ»¯Ñ§070300£¬Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
277²ÄÁÏ¿ÆÑ§Ó빤³Ì080500Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
317Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
280·ÖÇóµ÷¼Á Ò»Ö¾Ô¸085802
ÒѾÓÐ7È˻ظ´
0854µç×ÓÐÅÏ¢Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
263Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´













»Ø¸´´ËÂ¥
